Clinical Trial Update: Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation? [Phase 2]

View source ↗

Summary

Phase 2 trial in plaque psoriasis evaluating early intervention with bimekizumab; currently recruiting at CHU Nice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Psoriasis | Phase 2 | Status: RECRUITING